Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Taletrectinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nuvation Gets China NMPA Nod For Taletrectinib In ROS1+ NSCLC
    Nuvation Gets China NMPA Nod For Taletrectinib In ROS1+ NSCLC

    06 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250106610712/en

    BUSINESSWIRE
    06 Jan 2025
    Share Share
    Innovent’s Dovbleron Gets Second NDA Approval from NMPA
    Innovent’s Dovbleron Gets Second NDA Approval from NMPA

    02 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innovent-announces-second-new-drug-application-of-dovbleron--taletrectinib-adipate-capsule-ros1-inhibitor-was-approved-by-chinas-national-medical-products-administration-302341276.html

    PR NEWSWIRE
    02 Jan 2025
    Share Share
    FDA Accepts Nuvation’s Taletrectinib for Review in ROS1+ NSCLC
    FDA Accepts Nuvation’s Taletrectinib for Review in ROS1+ NSCLC

    23 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241223905597/en

    BUSINESSWIRE
    23 Dec 2024
    Share Share
    Innovent Receives Approval for Dovbleron by China’s NMPA
    Innovent Receives Approval for Dovbleron by China’s NMPA

    20 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innovent-receives-approval-of-dovbleron-taletrectinib-adipate-capsule-ros1-inhibitor-by-chinas-national-medical-products-administration-302337248.html

    PR NEWSWIRE
    20 Dec 2024
    Share Share
    Nuvation Bio Appoints Philippe Sauvage As Chief Financial Officer
    Nuvation Bio Appoints Philippe Sauvage As Chief Financial Officer

    07 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241007470241/en

    BUSINESSWIRE
    07 Oct 2024
    Share Share
    Nuvation Bio Reports Q2 2024 Results And Business Update
    Nuvation Bio Reports Q2 2024 Results And Business Update

    05 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240805155584/en

    BUSINESSWIRE
    05 Aug 2024
    Share Share